Nexam Chemical Holding AB

As of June 30, 2026, Nexam Chemical Holding AB carries a market capitalization of 326.47M, placing it among publicly traded companies globally. Its enterprise value stands at 322.24M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Nexam Chemical Holding AB's next confirmed earnings release is scheduled for January 29, 2027.

As of June 30, 2026, Nexam Chemical Holding AB has 102.66M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.39, and the price-to-book ratio stands at 1.56.

As of June 30, 2026, Nexam Chemical Holding AB trades at an EV/EBITDA multiple of 74.04 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 322.24M versus a market cap of 326.47M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Nexam Chemical Holding AB maintains a current ratio of 2.92, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.90, indicating elevated leverage, while an interest coverage ratio of 1.32 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Nexam Chemical Holding AB posted a negative return on equity (ROE) of -7.67, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -6.04, reflecting losses generated across the asset base. The company generates approximately 3.46M in revenue per employee across its workforce of 58.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.75 indicates how many times Nexam Chemical Holding AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Nexam Chemical Holding AB recorded 791,000.00 in income tax expense. The company reported a pretax loss of -14.12M and -14.92M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Nexam Chemical Holding AB's stock has declined approximately 25.45% over the past 52 weeks. The 50-day moving average sits at 2.85, while the 200-day moving average is 2.81.

Over the twelve months ended June 30, 2026, Nexam Chemical Holding AB generated 201.38M in revenue and converted that into -14.92M in net income, yielding earnings per share of -0.17. EBITDA reached 4.35M, while operating income came in at -12.31M.

As of June 30, 2026, Nexam Chemical Holding AB holds 22.90M in cash and equivalents against 18.67M in total debt, resulting in a net debt position of -4.22M. Total book value stands at 209.70M, with working capital of 73.61M providing operational flexibility.

Nexam Chemical Holding AB produced -12.97M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Nexam Chemical Holding AB posted a gross margin of 47.62, reflecting its pricing power and cost economics. The operating margin of -6.11 and net profit margin of -7.41 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -4.63: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -12.38, meaning Nexam Chemical Holding AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Nexam Chemical Holding AB has an Altman Z-Score of 2.97, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.